International Journal of Pharmaceutics 1991: Vol 67 Index

3 Pages·1991·0.61 MB·English

International Journal of Pharmaceutics, 67 (1991) 283-285
© 1991 Elsevier Science Publishers B.V. (Biomedical Division) 0378-/5911 /7$033.5 0
Author Index
Al-Gohary, O.M.N. Fernandez-Arévalo, M., see Rabasco, A.M. (67) 201
An in vitro study of the interaction between mebeverine Fukuzaki, H., see Asano, M. (67) 67
hydrochloride and magnesium trisilicate powder (67) 89
Alonso, M.J., see Egea, M.A. (67) 103
Ganderton, D., see Leigh, T.R. (67) 275
Alsina, M.A., see Egea, M.A. (67) 103 Garcia, M.L., see Egea, M.A. (67) 103
Arafat, T., see Sallam, E. (67) 247
Ginés, J.M., see Rabasco, A.M. (67) 201
Aramaki, Y., see Hara, T. (67) 123 Goémez-Amoza, J.L., see Pérez-Marcos, B. (67) 113
Asano, M., Fukuzaki, H., Yoshida, M.. Kumakura, M., Gonzalez, A.G. and De Pablos Pons, F.
Mashimo, T., Yuasa, H., Imai, K., Yamanaka, H., Kawa-
Evaluation of acidity constants for sparingly soluble com-
harada, U. and Suzuki, K. pounds from fluorescence measurements (67) R1
In vivo controlled release of a luteinizing hormone-releas- Gutiérrez, C., see Pérez-Marcos, B. (67) 113
ing hormone agonist from poly(DL-lactic acid) formula-
tions of varying degradation pattern (67) 67
Awad, R., see Sallam, E. (67) 247 Hadzija, B.W., Obeng, E.K., Ruddy, S.B., Noormohammadi,
A. and Beckett, A.H.
Bioavailability of a controlled release indomethacin formu-
Baghal, T., see Sallam, E. (67) 247 lation in healthy subjects (67) 185
Beckett, A.H., see Hadzija, B.W. (67) 185 Hara, T., Ishihara, H., Aramaki, Y. and Tsuchiya, S.
Beijnen, J.H., see Van der Houwen, O.A.G.J. (67) 155 Characteristics of the binding of asialofetuin-labeled lipo-
Bekers, O., see Van der Houwen, O.A.G_J. (67) 155 somes to isolated rat hepatocytes (67) 123
Bos, C.E., Vromans, H. and Lerk, C.F. Hassan, M.A., Najib, N.M. and Suleiman, M.S.
Lubricant sensitivity in relation to bulk density for granula- Characterization of glibenclamide glassy state (67) 131
tions based on starch or cellulose (67) 39 Hiestand, E.N. and Smith, D.P.
Bouzon, J., see Laghoueg-Derriche, N. (67) 163 Tablet bond. II. Experimental check of model (67) 231
Bult, A., see Van der Houwen, O.A.G.J. (67) 155 Hiestand, E.N.
Tablet bond. I. A theoretical model (67) 217
Calvo, M.B., Pedraz, J.L., Vicente, M.T. and Dominguez-Gil, Hjartstam, J., see Lindstedt, B. (67) 21
A. Holgado, M.A., see Rabasco, A.M. (67) 201
Pharmacokinetics of cefazoline and dibenzylamine adminis-
tered in a sustained drug delivery system to healthy volun- Ibrahim, H., see Sallam, E. (67) 247
teers (67) 259
Imai, K., see Asano, M. (67) 67
Carstensen, H., Miiller, B.W. and Miller, R.H. Imai, T., Shiraishi, S.. Sait6, H. and Otagiri, M.
Adsorption of ethoxylated surfactants on nanoparticles. I. Interaction of indomethacin with low molecular weight
Characterization by hydrophobic interaction chromatogra- chitosan, and improvements of some pharmaceutical prop-
phy (67) 29 erties of indomethacin by low molecular weight chitosans
Chafi, N., Monthéard, J.P. and Vergnaud, J.M. (67) 11
Release of 2-aminothiazole from polymer carriers (67) 265 Ishihara, H., see Hara, T. (67) 123
Chang, H.W., see Yoon, EJ. (67) 177
Collins, J.V., see Leigh, T.R. (67) 275
Kawaharada, U., see Asano, M. (67) 67
Concheiro, A., see Pérez-Marcos, B. (67) 113
Kim, C.K., see Yoon, EJ. (67) 177
Kimura, T., see Kurosaki, Y. (67) 1
De Muynck, C., see Vandenbossche, G.M.R. (67) 195 Klimek, R., see Thoma, K. (67) 169
De Pablos Pons, F., see Gonzalez, A.G. (67) R1 Kohli, D.V., see Tripathi, M. (67) 207
Dominguez-Gil, A., see Calvo, M.B. (67) 259 Kumakura, M., see Asano, M. (67) 67
Kurosaki, Y., Nagahara, N., Tanizawa, T., Nishimura, H.,
Eerikidinen, S., see Laakso, R. (67) 79 Nakayama, T. and Kimura, T.
Egea, M.A., Valls, O., Alsina, M.A., Garcia, M.L., Losa, C., Use of lipid disperse systems in transdermal drug delivery:
Vila-Jato, J.L. and Alonso, M.J. Comparative study of flufenamic acid permeation among
Interaction of amikacin loaded nanoparticles with phos- rat abdominal skin, silicon rubber membrane and stratum
phatidylcholine monolayers as membrane models (67) 103 corneum sheet isolated from hamster cheek pouch (67) 1
284
Laakso, R. and Eerikadinen, S. Rabasco, A.M., Ginés, J.M., Fernandez-Arévalo, M. and
Effects of core components on indomethacin release from Holgado, M.A.
film-coated granules (67) 79 Dissolution rate of diazepam from polyethylene glycol 6000
Laghoueg-Derriche, N. and Vergnaud, J.M. solid dispersions (67) 201
Modelling the process of drying of dosage forms made of Remon, J.P., see Vandenbossche, G.M.R. (67) 195
drug dispersed in a polymer (67) 51 Ruddy, S.B., see Hadzija, B.W. (67) 185
Laghoueg-Derriche, N., Bouzon, J. and Vergnaud, J.M.
Effect of temperature of the drying process of dosage forms Saitd, H., see Imai, T. (67) 11
prepared by a humidity technique (67) 163 Saket, M., see Sallam, E. (67) 247
Lee, H., see Yoon, E.J. (67) 177 Sallam, E., Ibrahim, H., Takieddin, M., Baghal, T., Saket, M.,
Lee, M.G., see Yoon, E.J. (67) 177 Awad, R. and Arafat, T.
Leigh, T.R., Nazir, T., Wiggins, J.. Ganderton, D. and Collins, Dissolution characteristics of interactive powder mixtures.
JV. 4. Effects of additives on the dissolution of griseofulvin
Performance characteristics of the DeVilbiss Ultraneb 99 from Emcompress carrier (67) 247
ultrasonic nebuliser with reference to use in sputum induc- Shiraishi, S., see Imai, T. (67) 11
tion (67) 275 Shiu, G.K., see Su, S.Y. (67) 211
Lerk, C.F., see Bos, C.E. (67) 39 Simmons, J.E., see Su, S.Y. (67) 211
Lindstedt, B., Sjéberg, M. and Hjartstam, J. Sjéberg, M., see Lindstedt, B. (67) 21
Osmotic pumping release from KCl tablets coated with Sjdkvist, E. and Nystrém, C.
porous and non-porous ethylcellulose (67) 21 Physicochemical aspects of drug release. XI. Tableting
Loftsson, T. and Olafsdéttir, BJ.
properties of solid dispersions, using xylitol as carrier
Cyclodextrin-accelerated degradation of B-lactam antibio- material (67) 139
tics in aqueous solutions (67) RS Skelly, J.P., see Su, S.Y. (67) 211
Losa, C., see Egea, M.A. (67) 103 Smith, D.P., see Hiestand, E.N. (67) 231
Souto, C., see Pérez-Marcos, B. (67) 113
Marshall, P.V. and York, P. Su, S.Y., Shiu, G.K., Simmons, J.E. and Skelly, J.P.
The compaction properties of nitrofurantoin samples crys- Some considerations on the analytical method for dissolu-
tallised from different solvents (67) 59 tion of conjugated estrogen tablets (67) 211
Martinez-Pacheco, R., see Pérez-Marcos, B. (67) 113 Suleiman, M.S., see Hassan, M.A. (67) 131
Mashimo, T., see Asano, M. (67) 67 Suzuki, K., see Asano, M. (67) 67
Monthéard, J.P., see Chafi, N. (67) 265
Miiller, B.W., see Carstensen, H. (67) 29 Takieddin, M., see Sallam, E. (67) 247
Miiller, R.H., see Carstensen, H. (67) 29 Tanizawa, T., see Kurosaki, Y. (67) 1
Thoma, K. and Klimek, R.
Photostabilization of drugs in dosage forms without protec-
Nagahara, N., see Kurosaki, Y. (67) 1
tion from packaging materials (67) 169
Najib, N.M., see Hassan, M.A. (67) 131
Tripathi, M., Kohli, D.V. and Uppadhyay, R.K.
Nakayama, T., see Kurosaki, Y. (67) 1
Effect of cholic and deoxycholic acid conjugates on solubil-
Nazir, T., see Leigh, T.R. (67) 275
Niazy, E.M. ity and dissolution of indomethacin and phenylbutazone
(67) 207
Influence of oleic acid and other permeation promoters on
Tsuchiya, S., see Hara, T. (67) 123
transdermal delivery of dihydroergotamine through rabbit
skin (67) 97
Nishimura, H., see Kurosaki, Y. (67) 1 Underberg, W.J.M., see Van der Houwen, O.A.G.J. (67) 155
Uppadhyay, R.K., see Tripathi, M. (67) 207
Noormohammadi, A., see Hadzija, B.W. (67) 185
Nystrém, C., see Sjékvist, E. (67) 139
Valls, O., see Egea, M.A. (67) 103
Obeng, E.K., see Hadzija, B.W. (67) 185 Vandenbossche, G.M.R., Vanhaecke, E., De Muynck, C. and
Olafsdéttir, B.J., see Loftsson, T. (67) RS Remon, J.P.
Otagiri, M., see Imai, T. (67) 11 Stability of topical erythromycin formulations (67) 195
Van der Houwen, O.A.G.J., Bekers, O., Beijnen, J.H., Bult, A.
and Underberg, W.J.M.
Park, M.K., see Yoon, E.J. (67) 177 A general approach to the interpretation of pH degradation
Pedraz, J.L., see Calvo, M.B. (67) 259 profiles in the presence of ligands (67) 155
Pérez-Marcos, B., Gutiérrez, C., Gémez-Amoza, J.L., Vanhaecke, E., see Vandenbossche, G.M.R. (67) 195
Martinez-Pacheco, R., Souto, C. and Concheiro, A. Vergnaud, J.M., see Chafi, N. (67) 265
Usefulness of certain varieties of Carbomer in the formula- Vergnaud, J.M., see Laghoueg-Derriche, N. (67) 51
tion of hydrophilic furosemide matrices (67) 113 Vergnaud, J.M., see Laghoueg-Derriche, N. (67) 163
285
Vicente, M.T., see Calvo, M.B. (67) 259 Pharmacokinetics of methotrexate after intravenous infu-
Vila-Jato, J.L., see Egea, M.A. (67) 103 sion of methotrexate-rabbit serum albumin conjugate to
Vromans, H., see Bos, C.E. (67) 39 rabbits (67) 177
York, P., see Marshall, P.V. (67) 59
Wiggins, J., see Leigh, T.R. (67) 275 Yoshida, M., see Asano, M. (67) 67
Yuasa, H., see Asano, M. (67) 67
Yamanaka, H., see Asano, M. (67) 67
Yoon, E.J., Chang, H.W., Lee, M.G., Lee, H., Park, M.K. and
Kim, C.K.